A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom
Study sponsor: Novavax
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-03-29Actual
Enrollment · participants15185Actual
Source updated2025-05-08Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.